Inventiva IVA
NASDAQ IVA
$3.29 -0.24 (-6.80%)
At close: Sep 29, 2026 · 4:00 PM EDT

Inventiva (IVA) Research & Development (2020 - 2021)

Updated

Inventiva (IVA) reported Research & Development of -$101.32 million for FY2025, compared with -$97.11 million in FY2024.

Analysis

Inventiva (IVA) Research & Development (2020 - 2021) Analysis & Trends

Dating back to FY2018, Inventiva's Research & Development record includes 8 years.

  • Five-year annual Research & Development spans a low of -$118.37 million in FY2023 and a high of -$57.34 million in FY2021.
  • According to Business Quant data, Research & Development came in at -$97.11 million in FY2024, -$118.37 million in FY2023, -$61.69 million in FY2022 and -$57.34 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Inventiva 682.13 Mn 682.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -14.35 Mn
Mar 31, 2021 -8.68 Mn
Jun 30, 2020 -7.18 Mn
Mar 31, 2020 -6.69 Mn
API Access

Inventiva Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=IVA&period=max&api_key=YOUR_API_KEY